1
|
Repurposing colchicine's journey in view of drug-to-drug interactions. A review. Toxicol Rep 2021; 8:1389-1393. [PMID: 34285885 PMCID: PMC8280530 DOI: 10.1016/j.toxrep.2021.07.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Revised: 05/10/2021] [Accepted: 07/08/2021] [Indexed: 12/15/2022] Open
Abstract
Colchicine's medical evolution is historically bound to the Mediterranean basin, since remarkable researchers from this region underscored its valuable properties. With the passing of years colchicine became an essential pharmaceutical substance for the treatment of rheumatologic and cardiovascular diseases. In light of recent findings, the therapeutic value of colchicine has grown. In clinical practice, colchicine remains underutilized in view of its proven efficacy and safety. Its complex pharmacokinetics and multifaceted anti-inflammatory role remain under investigation. The current review addresses the safe administration of colchicine in view of key drug to drug interactions. Finally, we are briefly presenting colchicine's future potential applications.
Collapse
|
2
|
Gintonin influences the morphology and motility of adult brain neurons via LPA receptors. J Ginseng Res 2020; 45:401-407. [PMID: 34025133 PMCID: PMC8134845 DOI: 10.1016/j.jgr.2020.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Revised: 06/10/2020] [Accepted: 06/30/2020] [Indexed: 11/02/2022] Open
Abstract
Background Gintonin is an exogenous ginseng-derived G-protein-coupled lysophosphatidic acid (LPA) receptor ligand. LPA induces in vitro morphological changes and migration through neuronal LPA1 receptor. Recently, we reported that systemic administration of gintonin increases blood-brain barrier (BBB) permeability via the paracellular pathway and its binding to brain neurons. However, little is known about the influences of gintonin on in vivo neuron morphology and migration in the brain. Materials and methods We examined the effects of gintonin on in vitro migration and morphology using primary hippocampal neural precursor cells (hNPC) and in vivo effects of gintonin on adult brain neurons using real time microscopic analysis and immunohistochemical analysis to observe the morphological and locational changes induced by gintonin treatment. Results We found that treating hNPCs with gintonin induced morphological changes with a cell rounding following cell aggregation and return to individual neurons with time relapses. However, the in vitro effects of gintonin on hNPCs were blocked by the LPA1/3 receptor antagonist, Ki16425, and Rho kinase inhibitor, Y27632. We also examined the in vivo effects of gintonin on the morphological changes and migration of neurons in adult mouse brains using anti-NeuN and -neurofilament H antibodies. We found that acute intravenous administration of gintonin induced morphological and migrational changes in brain neurons. Gintonin induced some migrations of neurons with shortened neurofilament H in the cortex. The in vivo effects of gintonin were also blocked by Ki16425. Conclusion The present report raises the possibility that gintonin could enter the brain and exert its influences on the migration and morphology of adult mouse brain neurons and possibly explains the therapeutic effects of neurological diseases behind the gintonin administration.
Collapse
Key Words
- Adult brain neuron
- BBB, blood brain barrier
- BSA, bovine serum albumin
- DAPI, 4′,6-diamidino-2-phenylindole
- DMEM, Dulbecco's modified Eagle's medium
- DMSO, dimethyl sulfoxide
- EGF, epidermal growth factor
- FITC, fluorescein isothiocyanate
- Gintonin
- HBSS, Hanks' Balanced Salt Solution
- LPA receptors
- LPA, Lysophatidic Acid
- MEM, Modified Eagle's medium
- Morphology and migration
- NECAB1, Neuronal calcium binding proteins 1
- NFH, neurofilament H
- OCT, optimum cutting temperature
- PFA, paraformaldehyde
- ROCK, Rho-associated protein kinase
- bFGF, fibroblast growth factor
- hNPC, hippocampal neural precursor cells
Collapse
|
3
|
Anti-platelet role of Korean ginseng and ginsenosides in cardiovascular diseases. J Ginseng Res 2020; 44:24-32. [PMID: 32095094 PMCID: PMC7033355 DOI: 10.1016/j.jgr.2019.05.005] [Citation(s) in RCA: 48] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2019] [Revised: 05/13/2019] [Accepted: 05/14/2019] [Indexed: 11/22/2022] Open
Abstract
Cardiovascular diseases prevail among modern societies and underdeveloped countries, and a high mortality rate has also been reported by the World Health Organization affecting millions of people worldwide. Hyperactive platelets are the major culprits in thrombotic disorders. A group of drugs is available to deal with such platelet-related disorders; however, sometimes, side effects and complications caused by these drugs outweigh their benefits. Ginseng and its nutraceuticals have been reported to reduce the impact of thrombotic conditions and improve cardiovascular health by antiplatelet mechanisms. This review provides (1) a comprehensive insight into the available pharmacological options from ginseng and ginsenosides (saponin and nonsaponin fractions) for platelet-originated cardiovascular disorders; (2) a discussion on the impact of specific functional groups on the modulation of platelet functions and how structural modifications among ginsenosides affect platelet activation, which may further provide a basis for drug design, optimization, and the development of ginsenoside scaffolds as pharmacological antiplatelet agents; (3) an insight into the synergistic effects of ginsenosides on platelet functions; and (4) a perspective on future research and the development of ginseng and ginsenosides as super nutraceuticals.
Collapse
Key Words
- AA, arachidonic acid
- AC, adenylyl cyclase
- ADP, adenosine diphosphate
- ASA, acetylsalicylic acid
- ATP, adenosine triphosphate
- Akt, protein kinase B
- Antiplatelet
- COX, cyclooxygenase
- CRP, collagen-related peptide
- CSF, crude saponin fraction
- ERK, extracellular signal–regulated kinase
- GPVI, glycoprotein VI
- Ginsenosides
- IC50, half maximal (50%) inhibitory concentration
- IP3, inositol-1,4,5-triphosphate
- JNK, c-Jun N-terminal kinase
- MAPK, mitogen-activated protein kinase
- MKK4, mitogen-activated protein kinase kinase 4
- MLC, myosin light chain
- Nutraceutical
- PAF, platelet-activating factor
- PAR, proteinase-activated receptor
- PI3K, phosphatidylinositol 3-kinase
- PKA, protein kinase A
- PKC, protein kinase C
- PKG, protein kinase G
- PLA2, phospholipase A2
- PLCγ2, phospholipase C gamma-2
- PPD, protopanaxadiol
- PPT, protopanaxatriol
- PT, prothrombin time
- ROCK, Rho-associated protein kinase
- SFK, Src family kinase
- Structural modification
- Syk, spleen tyrosine kinase
- Synergism
- TS, total saponin
- TxA2, thromboxane A2
- TxAS, thromboxane-A synthase
- TxB2, thromboxane B2
- TxR, thromboxane receptor
- VASP, vasodilator-stimulated phosphoprotein
- [Ca2+]i, intracellular calcium ion
- aPTT, activated partial thromboplastin time
- cAMP, cyclic adenosine monophosphate
- cPLA2α, cytosolic phospholipase A2α
- vWF, von Willebrand factor
Collapse
|
4
|
Effect of N-arachidonoyl-l-serine on human cerebromicrovascular endothelium. Biochem Biophys Rep 2016; 8:254-260. [PMID: 28955964 PMCID: PMC5613961 DOI: 10.1016/j.bbrep.2016.09.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2016] [Revised: 06/24/2016] [Accepted: 09/14/2016] [Indexed: 01/22/2023] Open
Abstract
N-arachidonoyl-l-serine (ARA-S) is an endogenous lipid, chemically related to the endocannabinoid, N-arachidonoyl ethanolamine (i.e., anandamide) and with similar physiologic and pathophysiologic functions. Reports indicate that ARA-S possesses vasoactive and neuroprotective properties resembling those of cannabinoids. However, in contrast to cannabinoids, ARA-S binds weakly to its known classical receptors, CB1 and CB2, and is therefore considered to be a 'cannabinoid-like' substance. The originally described ARA-S induced-endothelial-dependent vasorelaxation was not abrogated by CB1, CB2 receptor antagonists or TRPV1 competitive inhibitor. The present report demonstrates that ARA-S enhances the fluorescence staining of both cannabinoid receptors (CB1 and CB2) in human brain endothelial cells (HBEC). This reaction is specific since it was reduced by respective selective receptor antagonist (SR141716A and SR141728A). ARA-S alone or in the presence of ET-1 was shown to alter the cytoskeleton (actin). Both ARA-S stimulated phosphorylation of various kinases (MAPK, Akt, JNK and c-JUN) and alteration of cytoskeleton are mediated via CB1, CB2 and TRPV1 receptors. The findings also showed the involvement of Rho/Rock and PI3/Akt/NO pathways in the ARA-S-induced phosphorylation of kinases and actin reorganization in HBEC. All of the above mentioned ARA-S-induced effects were reduced by the treatment with LY294002 (inhibitor of PI3/Akt kinase), except MAPK kinase. In addition, MAPK, JNK, c-JUN phosphorylation were inhibited by H1152 (inhibitor of Rho/ROCK kinase), except Akt kinase. Furthermore, PI3/Akt pathway was inhibited by pretreatment with l-NAME (inhibitor of NOS). The findings suggest that ARA-S is a modulator of Rho kinase and may play a critical role in the regulation of its activity and subsequent effects on the cytoskeleton and its role in supporting essential cell functions like vasodilation, proliferation and movement.
Collapse
Key Words
- 2-AG, 2-Arachidonoylglycerol
- ARA-S, N-arachidonoyl-l-serine
- CB1 receptor, cannabinoid receptor 1
- CB2 receptor, cannabinoid receptor 2
- Cannabinoid-like agent
- Cytoskeleton
- ET-1, Endothelin 1
- Endothelin-1
- Erk1/2, extracellular signal-regulated kinases 1and 2
- GPR55, G protein-coupled receptor 55
- HBEC, Human brain endothelial cells
- Human brain endothelial cells
- JNK, c-JUN N-terminal kinase
- L-NAME, L-NG-Nitroarginine methyl ester
- MAPK, Mitogen-activated protein kinases
- N-arachidonoyl-L-serine
- NO, nitric oxide
- PI3, Phosphatidylinositol-4,5-bisphosphate 3-kinase
- ROCK, Rho-associated protein kinase
- Signal transduction pathway
- TPRV1, transient receptor potential vanilloid receptor 1
- e-NOS, endothelial nitric oxide synthetase
Collapse
|
5
|
Abstract
Tissue development is orchestrated by the coordinated activities of both chemical and physical regulators. While much attention has been given to the role that chemical regulators play in driving development, researchers have recently begun to elucidate the important role that the mechanical properties of the extracellular environment play. For instance, the stiffness of the extracellular environment has a role in orienting cell division, maintaining tissue boundaries, directing cell migration, and driving differentiation. In addition, extracellular matrix stiffness is important for maintaining normal tissue homeostasis, and when matrix mechanics become imbalanced, disease progression may ensue. In this article, we will review the important role that matrix stiffness plays in dictating cell behavior during development, tissue homeostasis, and disease progression.
Collapse
Key Words
- ECM, Extracellular matrix
- EPC, Endothelial progenitor cell
- FA, Focal adhesion
- FAK, Focal adhesion kinase
- LOX, Lysyl oxidase
- MKL1, Megakaryoblastic leukemia factor-1
- MMP, Matrix metalloproteinase
- MSC, Mesenchymal stem cell
- ROCK, Rho-associated protein kinase
- VSMC, Vascular smooth muscle cell.
- cancer
- extracellular matrix
- fibrosis
- stiffness
- tissue development
- tissue homeostasis
Collapse
|
6
|
Abstract
The establishment and maintenance of epithelial cell-cell junctions is crucially important to regulate adhesion, apico-basal polarity and motility of epithelial cells, and ultimately controls the architecture and physiology of epithelial organs. Junctions are supported, shaped and regulated by cytoskeletal filaments, whose dynamic organization and contractility are finely tuned by GTPases of the Rho family, primarily RhoA, Rac1 and Cdc42. Recent research has identified new molecular mechanisms underlying the cross-talk between these GTPases and epithelial junctions. Here we briefly summarize the current knowledge about the organization, molecular evolution and cytoskeletal anchoring of cell-cell junctions, and we comment on the most recent advances in the characterization of the interactions between Rho GTPases and junctional proteins, and their consequences with regards to junction assembly and regulation of cell behavior in vertebrate model systems. The concept of “zonular signalosome” is proposed, which highlights the close functional relationship between proteins of zonular junctions (zonulae occludentes and adhaerentes) and the control of cytoskeletal organization and signaling through Rho GTPases, transcription factors, and their effectors.
Collapse
Key Words
- AJ, adherens junction
- AMOT, angiomotin
- AMPK, Adenosine Monophosphate-Activated Protein Kinase
- APC, adenomatous poliposis coli
- CD2AP, CD2-associated protein
- CGN, cingulin
- CGNL1, paracingulin
- Cdc42
- Cdc42, cell division cycle 42
- DLC, deleted in liver cancer
- Dbl, diffuse B-cell lymphoma
- EPLIN, epithelial protein lost in neoplasm
- ERK, extracellular regulated kinase
- FERM, four.point.one, ezrin, radixin, moesin
- FGD5, FYVE, RhoGEF and PH domain containing 5
- GAP, GTPase activating protein
- GEF, guanine nucleotide exchange factor
- GST, glutathione -S- transferase; JAM = junctional adhesion molecule
- MCF-7, Michigan Cancer Foundation - 7
- MDCK, Madin Darby Canine Kidney
- MKLP1, mitotic kinesin-like protein-1
- MRCK, myotonic dystrophy-related Cdc42-binding kinase
- MgcRacGAP, male germ cell racGAP
- PA, puncta adhaerentia
- PAK, p21-activated kinase; PATJ, Pals1 associated tight junction protein
- PCNA, proliferating cell nuclear antigen
- PDZ, Post synaptic density protein (PSD95), Drosophila, disc large tumour suppressor (DlgA), and zonula occludens-1
- PLEKHA7, pleckstrin homology domain containing, family A member 7
- RICH-1, RhoGAP interacting with CIP4 homologues
- ROCK, Rho-associated protein kinase
- Rac
- Rho
- SH3BP1, (SH3 domain 490 binding protein-1)
- TJ, tight junction
- Tbx-3, T-box-3
- Tiam, Tumor invasion and metastasis
- WASP, Wiskott-Aldrich Syndrome Protein
- WAVE, WASP family Verprolin-homologous protein
- ZA, zonula adhaerens
- ZO, zonula occludens
- ZONAB, (ZO-1)–associated nucleic acid binding protein.
- cytoseleton
- epithelium
- junctions
Collapse
|
7
|
Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review. Arab J Urol 2015; 13:155-61. [PMID: 26413339 PMCID: PMC4563010 DOI: 10.1016/j.aju.2015.06.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2014] [Revised: 05/15/2015] [Accepted: 06/10/2015] [Indexed: 01/01/2023] Open
Abstract
Many men have coexistent erectile dysfunction (ED) and lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH). Phosphodiesterase type 5 (PDE5) inhibitors are effective for treating both of these conditions independently. In this review we summarise the evidence supporting a link between ED and LUTS/BPH, and the results from key clinical studies related to the use of PDE5 inhibitors for treating both conditions. The results from these studies suggest that men who have both ED and LUTS/BPH, and are concerned about their sexual dysfunction, might benefit from single-agent, holistic treatment with a PDE5 inhibitor.
Collapse
Key Words
- 5ARI, 5α-reductase inhibitor
- AE, adverse event
- Benign prostatic hyperplasia
- ED, erectile dysfunction
- EF, erectile function (domain)
- Erectile dysfunction
- IIEF, International Index of Erectile Function
- LUTS
- NO, nitric oxide
- PDE5 inhibitor
- PDE5, phosphodiesterase type 5
- QoL, quality of life
- ROCK, Rho-associated protein kinase
- RhoA, Ras homologue gene family member A
- cGMP, cyclic guanosine monophosphate
Collapse
|
8
|
Synthetic polyamines: new compounds specific to actin dynamics for mammalian cell and fission yeast. BIOARCHITECTURE 2015; 4:144-8. [PMID: 25664996 DOI: 10.4161/19490992.2014.965111] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Actin is a major actor in the determination of cell shape. On the one hand, site-directed assembly/disassembly cycles of actin filaments drive protrusive force leading to lamellipodia and filopodia dynamics. Force produced by actin similarly contributes in membrane scission in endocytosis or Golgi remodeling. On the other hand, cellular processes like adhesion, immune synapse, cortex dynamics or cytokinesis are achieved by combining acto-myosin contractility and actin assembly in a complex and not fully understood manner. New chemical compounds are therefore needed to disentangle acto-myosin and actin dynamics. We have found that synthetic, cell permeant, short polyamines are promising new actin regulators in this context. They generate growth and stabilization of lamellipodia within minutes by slowing down the actin assembly/disassembly cycle and facilitating nucleation. We now report that these polyamines also slow down cytokinetic ring closure in fission yeast. This shows that these synthetic compounds are active also in yeasts, and these experiments specifically highlight that actin depolymerization is involved in the ring closure. Thus, synthetic polyamines appear to be potentially powerful agents in a quantitative approach to the role of actin in complex processes in cell biology, developmental biology and potentially cancer research.
Collapse
|